Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer

Author：                

Publisher： Spandidos Publications

E-ISSN： 1791-3004|12|1|1219-1224

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.1, 2015-01, pp. : 1219-1224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas

By              

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 2019-2022

Spandidos Publications

Access to resources Recommend Favorite

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer

By Soeda Hiroshi   Shimodaira Hideki   Watanabe Mika   Suzuki Takao   Gamoh Makio   Mori Takahiro   Komine Keigo   Iwama Noriyuki   Kato Shunsuke   Ishioka Chikashi  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 670-677

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer

By                  

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2519-2526

Spandidos Publications

Access to resources Recommend Favorite

PIK3CA mutations in breast cancer are associated with poor outcome

By Li Shao   Rong Minna   Grieu Fabienne   Iacopetta Barry  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 91-95

Springer Publishing Company

Access to resources Recommend Favorite

Mutations of the PIK3CA gene in ovarian and breast cancer

By Bellacosa Alfonso  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 223-225

Informa Healthcare

Access to resources Recommend Favorite